Variable | Survivors (n = 370) | Non-survivors (n = 110) | P-value |
---|---|---|---|
Age (year) | 58 ± 11 | 68 ± 13 | < 0.001 |
Female n (%) | 80 (22) | 37 (34) | 0.010 |
Hypertension n (%) | 151 (41) | 63 (57) | 0.002 |
Diabetes mellitus n (%) | 78 (21) | 37 (34) | 0.007 |
Hyperlipidemia n (%) | 76 (21) | 24 (22) | 0.772 |
Current smoking n (%) | 168 (45) | 40 (36) | 0.098 |
Previous CAD n (%) | 64 (17) | 27 (25) | 0.089 |
Prior stroke/TIA n (%) | 5 (1) | 9 (8) | < 0.001 |
Killip class ≥2 n (%) | 21 (6) | 20 (18) | < 0.001 |
Multi-vessel disease n (%) | 132 (36) | 57 (52) | 0.002 |
GP IIb/IIIa inhibitors n (%) | 107 (29) | 37 (34) | 0.343 |
Medication at discharge | |||
Beta-blocker n (%) | 319 (86) | 82 (73) | 0.004 |
Statin n (%) | 312 (84) | 85 (77) | 0.086 |
ACE-I/ARB n (%) | 315 (85) | 76 (69) | < 0.001 |
DAPT n (%) | 365 (99) | 107 (97) | 0.322 |
Infarct related artery | 0.097 | ||
LAD n (%) | 170 (46) | 50 (46) | |
Cx n (%) | 57 (15) | 8 (7) | |
RCA n (%) | 129 (35) | 49 (45) | |
Others n (%) | 14 (4) | 3 (2) | |
Outcomes | |||
30-day death n (%) | 0 (0) | 19 (17) | < 0.001 |
Stroke n (%) | 7 (2) | 5 (5) | 0.118 |
HF admission n (%) | 7 (2) | 15 (14) | < 0.001 |
Myocardial reinfarction n (%) | 30 (8) | 8 (7) | 0.776 |
TVR n (%) | 45 (12) | 11 (10) | 0.535 |